Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SOM.AX
SellSomnoMed Limited · Healthcare · Australia · $53M · Avg Vol: $19K/d
30
StockRankGet insider-trade alerts
Q
57
V
45
M
15
P/E (TTM)
—
ROE
-5.2%
D/E
0.1x
Dividend %
—
Loading 1Y...
PRICE (1Y)-23.0%
SMA 50SMA 200
Close
$0.24
RSI (14)
29.0
52W High
$0.677
From 52W High
0.4%
SCORE BREAKDOWN
Quality
57
ROIC
-15.7%32.9
ROE
-5.2%40.8
GP/Assets
93.1%97.3
Op. Margin
4.6%53.8
FCF/Assets
2.4%57.3
Piotroski
376.5
Int. Cover
-2.9x31.6
D/E Ratio
0.13x58.7
Current Ratio
1.76x33.6
Value
45
P/E (TTM)
—N/A
EV/EBITDA
16.5x42.4
P/FCF
40.5x34.5
P/B
1.4x73.1
P/S
0.6x90.6
Div Yield
—N/A
Momentum
15
52W High %
35%10.5
RS 6M
-51%14.6
SMA 50/200
0.73x10.8
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$53M
P/E (Forward)
12.7x
Gross Margin
59.8%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SOM.AX are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SOM.AX | SomnoMed Limited(you) | $53M | 30 | Sell |
| COV.AX | Cleo Diagnostics Ltd | $54M | 6 | Strong Sell |
| EMV.AX | EMVision Medical Devices Ltd | $117M | 14 | Strong Sell |
| PNV.AX | PolyNovo Limited | $512M | 33 | Sell |
| AVR.AX | Anteris Technologies Global Corp. | $846M | 26 | Sell |
| 4DX.AX | 4DMedical Limited | $1.6B | 11 | Strong Sell |
| ATX.AX | Amplia Therapeutics Limited | $55M | 30 | Sell |
| LTP.AX | LTR Pharma Limited | $65M | 24 | Sell |
| PTX.AX | Prescient Therapeutics Limited | $59M | 22 | Sell |
| ATH.AX | Alterity Therapeutics Limited | $80M | 28 | Sell |
Peer medians: ROE -27.4% · P/E 35.3x · Gross margin 61.9%